18 - Number group
SOTHEMA AT A GLANCE
The Group in figures
+1 600
Employees
10
Specialized industrial units
+350
Products marketed
13%
Market share in Morocco
+35
Export Markets
50
International partners
6
Subsidiaries and participations
+3,5
Billions MAD consolidated revenues in 2025
15 - Subsidiary card with logo
GROUP
The Group's subsidiaries
A subsidiary specializing in oncology, hematology, autoimmune diseases and next-generation innovative therapies.
Founded in 1996, Soludia is the leader in hemodialysis in Morocco. It has a strong industrial capacity, with over 50% market share in bicarbonate cartridges and significant production of acid solutions.
Dakar-based industrial and commercial platform serving West Africa, specializing in liquid and dry forms.
Our subsidiary dedicated to the group's international development.
15 - Filiale card avec logo
The Group's participations
A subsidiary dedicated to the production and distribution of medical devices.
A french biotech specialized in developing innovative diagnostic solutions in women's health, particularly for endometriosis.
9 - big Card content 2 cols
EXPERTISE
Our areas of expertise
The Sothema Group focuses its efforts on high-impact areas for public health, such as cardiovascular disease, diabetes, oncology, pain and autoimmune diseases.
The Group's activity is based on the following 4 areas:
Chronic Care & General Medicine
The most commonly prescribed general medical drugs treat common ailments such as pain and fever, or infections and digestive disorders. They also include treatments for chronic diseases, whether cardiovascular, endocrine or those relating to anxiety disorders.
Specialty products: Oncology - Immunotherapy - Hematology
"Specialty products" include complex biological drugs (biomedicines), often derived from biotechnology that target serious pathologies such as cancer or autoimmune diseases.
Dialysis products
Soludia offers an integrated range of products dedicated to the management of kidney failure, covering dialysis concentrates (acid and bicarbonate), supportive treatments, as well as a complementary range of devices and consumables for dialysis centers.
Built to the highest quality standards, these products enable safe, effective, and personalized care for patients and healthcare professionals alike."
Wellness & Consumer Health
Wellness & Consumer Health is a natural extension of the Group's therapeutic platforms, addressing patients' needs for prevention, support and health maintenance.
Positioned within a care-centric approach, this activity aims to develop solutions that complement drug treatments in priority therapeutic areas such as women's health, metabolic health, the central nervous system and gastroenterology, thereby contributing to more comprehensive, patient-centered care.
23 - card image title and description
BUSINESS MODEL
A business model built around 3 pillars
Generics and biosimilars
Sothema develops and manufactures a wide range of generic medicines in strict compliance with the highest international standards and regulatory requirements. From oral forms to injectables, each product is designed with the same requirement in mind: to offer effective therapies that are accessible to as many people as possible - thus helping to meet one of the major challenges facing public health on a global scale.
Licensed products
With a portfolio of 50 international partners, Sothema achieves steady growth driven by the continuous launch of new therapeutic specialties from these strategic partnerships. Sothema also develops medicines under brands acquired from its partners.
Contract Manufacturing
With one of the most high-performing industrial facilities in the sector, Sothema is the trusted partner of national and international laboratories for manufacturing their pharmaceutical specialties.
This continuously growing activity, supported by solid partnerships with more than 50 european, american and moroccan laboratories, reflects the Group's commitment to quality.
28 - Connected people
TO FIND OUT MORE
More about the Group
Discover the pillars that shape the Group's identity, expertise and impact.